Manisha Narasimhan, Ph.D. | Regeneron Pharmaceuticals, Inc. |
Leonard S. Schleifer, M.D., Ph.D. | Regeneron Pharmaceuticals, Inc. |
George D. Yancopoulos | Regeneron Pharmaceuticals, Inc. |
Robert J. Terifay | Regeneron Pharmaceuticals, Inc. |
Robert E. Landry | Regeneron Pharmaceuticals, Inc. |
Christopher Raymond | Piper Jaffray Companies |
Geoffrey C. Porges | Leerink Partners LLC |
Ying Huang | Bank of America Merrill Lynch |
Robyn Karnauskas | Citigroup Global Markets, Inc. |
Matthew K. Harrison | Morgan Stanley & Co. LLC |
Cory W. Kasimov | JPMorgan Securities LLC |
Joshua Schimmer | Evercore ISI |
Welcome to the Regeneron Pharmaceuticals Q3 2017 earnings conference call. My name is Paulette, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded.